NO881246L - Fremgangsmaate for fremstilling av terapeutisk preparat inneholdende dsrna og virusinhibitor. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk preparat inneholdende dsrna og virusinhibitor.

Info

Publication number
NO881246L
NO881246L NO881246A NO881246A NO881246L NO 881246 L NO881246 L NO 881246L NO 881246 A NO881246 A NO 881246A NO 881246 A NO881246 A NO 881246A NO 881246 L NO881246 L NO 881246L
Authority
NO
Norway
Prior art keywords
preparation
procedure
virus inhibitor
containing dsrna
therapeutic
Prior art date
Application number
NO881246A
Other languages
English (en)
Norwegian (no)
Other versions
NO881246D0 (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO881246D0 publication Critical patent/NO881246D0/no
Publication of NO881246L publication Critical patent/NO881246L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO881246A 1987-03-23 1988-03-21 Fremgangsmaate for fremstilling av terapeutisk preparat inneholdende dsrna og virusinhibitor. NO881246L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2882387A 1987-03-23 1987-03-23
US07/125,097 US4950652A (en) 1987-03-23 1987-11-25 dsRNAs for combination therapy in the treatment of viral diseases

Publications (2)

Publication Number Publication Date
NO881246D0 NO881246D0 (no) 1988-03-21
NO881246L true NO881246L (no) 1988-09-26

Family

ID=26704119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881246A NO881246L (no) 1987-03-23 1988-03-21 Fremgangsmaate for fremstilling av terapeutisk preparat inneholdende dsrna og virusinhibitor.

Country Status (21)

Country Link
US (1) US4950652A (en, 2012)
EP (1) EP0286224B1 (en, 2012)
JP (1) JP2656938B2 (en, 2012)
KR (1) KR960013435B1 (en, 2012)
CN (1) CN1049357C (en, 2012)
AU (1) AU1256288A (en, 2012)
CA (1) CA1316832C (en, 2012)
DE (1) DE3876125T2 (en, 2012)
DK (1) DK156688A (en, 2012)
ES (1) ES2066782T3 (en, 2012)
FI (1) FI881305A7 (en, 2012)
GR (1) GR3006340T3 (en, 2012)
HU (1) HUT46542A (en, 2012)
IE (1) IE63823B1 (en, 2012)
IL (1) IL85646A (en, 2012)
NO (1) NO881246L (en, 2012)
NZ (1) NZ223868A (en, 2012)
OA (1) OA08724A (en, 2012)
PH (1) PH23333A (en, 2012)
PT (1) PT87039B (en, 2012)
RU (1) RU2016572C1 (en, 2012)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130206A (en) * 1980-07-07 2000-10-10 Hem Research, Inc. Treating viral infections associated with chronic fatigue with dsRNA
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
US5091374A (en) * 1987-07-17 1992-02-25 Hem Research Inc. Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
US5906980A (en) * 1987-07-17 1999-05-25 Hem Research Inc. Treatment of hepatitis with mismatched dsRNA
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
US4960592A (en) * 1989-04-17 1990-10-02 Lanocare Laboratories Lanolin and lanolin oil skin treatment composition
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6703418B2 (en) * 1991-02-26 2004-03-09 Unimed Pharmaceuticals, Inc. Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
CA2102221A1 (en) * 1991-04-16 1992-10-17 William Carter Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
EP0596912A4 (en) * 1991-07-16 1994-07-27 Hem Pharma Corp Modulation and diagnosis of cytokine dysfunctions.
US20030207813A1 (en) * 1996-12-09 2003-11-06 G.D. Searle Retroviral protease inhibitor combinations
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
CA2224008C (en) * 1995-06-07 2009-08-18 Trimeris, Inc. The treatment of hiv and other viral infections using combinatorial therapy
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2123339C1 (ru) * 1996-06-18 1998-12-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Противовирусное средство
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
JP2002515892A (ja) * 1997-01-17 2002-05-28 アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド サイトカインが関係する疾患治療法
LT4475B (lt) * 1997-02-28 1999-02-25 Virmantas Stunžėnas Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
AR013269A1 (es) * 1997-08-04 2000-12-13 Scras Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
FR2766711B1 (fr) * 1997-08-04 2001-02-02 Sod Conseils Rech Applic Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP1071762A4 (en) 1998-03-20 2003-09-24 Benitec Australia Ltd CONTROL OF GENE EXPRESSION
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
FR2776927B1 (fr) * 1998-04-07 2002-07-05 Univ Paris Curie Compositions pour la vectorisation de molecules
AU776150B2 (en) 1999-01-28 2004-08-26 Medical College Of Georgia Research Institute, Inc. Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
RU2172631C2 (ru) * 1999-10-08 2001-08-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Индуктор интерферона пролонгированного действия
AU2001227889A1 (en) 2000-01-14 2001-07-24 The United States of America, represented by The Secretary, Department of Health & Human Services Oligodeoxynucleotide and its use to induce an immune response
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US20080242627A1 (en) * 2000-08-02 2008-10-02 University Of Southern California Novel rna interference methods using dna-rna duplex constructs
DE10100588A1 (de) * 2001-01-09 2002-07-18 Ribopharma Ag Verfahren zur Hemmung der Expression eines Zielgens
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
US7354909B2 (en) 2001-08-14 2008-04-08 The United States Of America As Represented By Secretary Of The Department Of Health And Human Services Method for rapid generation of mature dendritic cells
EP1494684A2 (en) * 2001-12-14 2005-01-12 Hemispherx Biopharma USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
US7615227B2 (en) 2001-12-20 2009-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce angiogenesis
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
WO2003064626A2 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Double-stranded oligonucleotides
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003086280A2 (en) 2002-04-04 2003-10-23 Coley Pharmaceutical Gmbh Immunostimulatory g,u-containing oligoribonucleotides
US8263091B2 (en) 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
WO2005009337A2 (en) * 2003-05-16 2005-02-03 Hemispherx Biopharma Treating severe acute respiratory syndrome
WO2005007831A2 (en) * 2003-07-18 2005-01-27 Vanderbilt University Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like
EP1666059A4 (en) * 2003-08-11 2008-08-27 Univ Osaka Res Found NEW VACCINE WITH AN ADJUVANS FOR TRIGGERING ABSORBENT IMMUNITY
RU2272631C2 (ru) * 2004-04-20 2006-03-27 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") Синергическая композиция для ингибирования вич
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
CN102517292B (zh) * 2005-11-25 2014-12-24 佐蒂斯比利时股份有限公司 免疫刺激性寡核糖核苷酸
US8075877B2 (en) 2006-03-08 2011-12-13 Hemispherx Biopharma Broad spectrum immune and antiviral gene modulation by oral interferon
CN101437534A (zh) * 2006-03-08 2009-05-20 半球生物制药公司 口服干扰素的广谱免疫和抗病毒基因调节作用
WO2009056818A1 (en) * 2007-10-29 2009-05-07 Cipla Limited Novel antiretroviral combination
CN101990435A (zh) * 2008-02-15 2011-03-23 海米斯费克斯生物制药公司 Toll样受体3的选择性激动剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1238277A (en) * 1985-03-16 1988-06-21 Sandra N. Lehrman Antiviral nucleosides
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS

Also Published As

Publication number Publication date
JP2656938B2 (ja) 1997-09-24
DK156688A (da) 1988-09-24
KR960013435B1 (ko) 1996-10-05
NO881246D0 (no) 1988-03-21
OA08724A (fr) 1989-03-31
IL85646A (en) 1993-05-13
DE3876125T2 (de) 1993-06-09
EP0286224A2 (en) 1988-10-12
AU1256288A (en) 1988-09-22
KR880010777A (ko) 1988-10-24
ES2066782T3 (es) 1995-03-16
IE63823B1 (en) 1995-06-14
EP0286224B1 (en) 1992-11-25
CN1049357C (zh) 2000-02-16
RU2016572C1 (ru) 1994-07-30
GR3006340T3 (en, 2012) 1993-06-21
US4950652A (en) 1990-08-21
DK156688D0 (da) 1988-03-22
FI881305L (fi) 1988-09-24
IE880839L (en) 1988-09-23
HUT46542A (en) 1988-11-28
PH23333A (en) 1989-07-14
PT87039B (pt) 1992-11-30
FI881305A0 (fi) 1988-03-18
PT87039A (pt) 1988-04-01
JPS6425A (en) 1989-01-05
CN88101606A (zh) 1988-12-28
IL85646A0 (en) 1988-08-31
NZ223868A (en) 1991-02-26
DE3876125D1 (de) 1993-01-07
CA1316832C (en) 1993-04-27
EP0286224A3 (en) 1988-12-07
FI881305A7 (fi) 1988-09-24

Similar Documents

Publication Publication Date Title
NO881246D0 (no) Fremgangsmaate for fremstilling av terapeutisk preparat inneholdende dsrna og virusinhibitor.
NO872889D0 (no) Preparat og fremgangsmaate for stimulering av underjordiske formasjoner.
NO881344D0 (no) Fremgangsmaate til fremstilling av kvaternaere esteraminer og deres anvendelse.
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
NO882762L (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser.
NO904921D0 (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
NO872660D0 (no) Preparat og fremgangsmaate for stimulering av underjordiske formasjoner.
NO884638D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraliner, kromaner og beslektede forbindelser.
NO884052L (no) Fremgangsmaate for fremstilling av terapeutisk preparat.
NO893668D0 (no) Fremgangsmaate for fremstilling av reformede fiskeprodukter
NO883220D0 (no) Innretning og preparat for behandling av gommene.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO882335D0 (no) Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO901422L (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO884635D0 (no) Fremgangsmaate for behandling av most.
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
NO883987L (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
NO911028L (no) Ekstrudert, biaksialt strukket skumplastroer og fremgangsmaate til fremstilling av et saadant
NO902968D0 (no) Fremgangsmaate for behandling av boreslam.
DK641189D0 (da) Praeparat til behandling af glaucom og fremgangsmaade til fremstilling af et saadant praeparat